Dr Ola Engkvist, AstraZeneca, explains how the drug discovery process benefits from artificial intelligence and machine learning.
The Advantages of Machine Learning and Artificial Intelligence in the Drug Discovery Process
Video Nov 20, 2018
Promoting a healthy gut microbiome may be a powerful strategy for lowering cholesterol and other heart attack risk factors. In this video, Reza Ghadiri presents research on molecules that can alter the bacterial population of intestines to a healthier state and how they have shown – through experiments in mice – that this reduces cholesterol levels and strongly inhibits the thickened-artery condition known as atherosclerosis.WATCH NOW